Cargando…

Group testing via hypergraph factorization applied to COVID-19

Large scale screening is a critical tool in the life sciences, but is often limited by reagents, samples, or cost. An important recent example is the challenge of achieving widespread COVID-19 testing in the face of substantial resource constraints. To tackle this challenge, screening methods must e...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, David, Dey, Rounak, Lin, Xihong, Cleary, Brian, Dobriban, Edgar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983763/
https://www.ncbi.nlm.nih.gov/pubmed/35383149
http://dx.doi.org/10.1038/s41467-022-29389-z
_version_ 1784682029358514176
author Hong, David
Dey, Rounak
Lin, Xihong
Cleary, Brian
Dobriban, Edgar
author_facet Hong, David
Dey, Rounak
Lin, Xihong
Cleary, Brian
Dobriban, Edgar
author_sort Hong, David
collection PubMed
description Large scale screening is a critical tool in the life sciences, but is often limited by reagents, samples, or cost. An important recent example is the challenge of achieving widespread COVID-19 testing in the face of substantial resource constraints. To tackle this challenge, screening methods must efficiently use testing resources. However, given the global nature of the pandemic, they must also be simple (to aid implementation) and flexible (to be tailored for each setting). Here we propose HYPER, a group testing method based on hypergraph factorization. We provide theoretical characterizations under a general statistical model, and carefully evaluate HYPER with alternatives proposed for COVID-19 under realistic simulations of epidemic spread and viral kinetics. We find that HYPER matches or outperforms the alternatives across a broad range of testing-constrained environments, while also being simpler and more flexible. We provide an online tool to aid lab implementation: http://hyper.covid19-analysis.org.
format Online
Article
Text
id pubmed-8983763
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89837632022-04-22 Group testing via hypergraph factorization applied to COVID-19 Hong, David Dey, Rounak Lin, Xihong Cleary, Brian Dobriban, Edgar Nat Commun Article Large scale screening is a critical tool in the life sciences, but is often limited by reagents, samples, or cost. An important recent example is the challenge of achieving widespread COVID-19 testing in the face of substantial resource constraints. To tackle this challenge, screening methods must efficiently use testing resources. However, given the global nature of the pandemic, they must also be simple (to aid implementation) and flexible (to be tailored for each setting). Here we propose HYPER, a group testing method based on hypergraph factorization. We provide theoretical characterizations under a general statistical model, and carefully evaluate HYPER with alternatives proposed for COVID-19 under realistic simulations of epidemic spread and viral kinetics. We find that HYPER matches or outperforms the alternatives across a broad range of testing-constrained environments, while also being simpler and more flexible. We provide an online tool to aid lab implementation: http://hyper.covid19-analysis.org. Nature Publishing Group UK 2022-04-05 /pmc/articles/PMC8983763/ /pubmed/35383149 http://dx.doi.org/10.1038/s41467-022-29389-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hong, David
Dey, Rounak
Lin, Xihong
Cleary, Brian
Dobriban, Edgar
Group testing via hypergraph factorization applied to COVID-19
title Group testing via hypergraph factorization applied to COVID-19
title_full Group testing via hypergraph factorization applied to COVID-19
title_fullStr Group testing via hypergraph factorization applied to COVID-19
title_full_unstemmed Group testing via hypergraph factorization applied to COVID-19
title_short Group testing via hypergraph factorization applied to COVID-19
title_sort group testing via hypergraph factorization applied to covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983763/
https://www.ncbi.nlm.nih.gov/pubmed/35383149
http://dx.doi.org/10.1038/s41467-022-29389-z
work_keys_str_mv AT hongdavid grouptestingviahypergraphfactorizationappliedtocovid19
AT deyrounak grouptestingviahypergraphfactorizationappliedtocovid19
AT linxihong grouptestingviahypergraphfactorizationappliedtocovid19
AT clearybrian grouptestingviahypergraphfactorizationappliedtocovid19
AT dobribanedgar grouptestingviahypergraphfactorizationappliedtocovid19